SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-137703
Filing Date
2023-05-08
Accepted
2023-05-08 08:02:00
Documents
14
Period of Report
2023-05-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d450090d8k.htm   iXBRL 8-K 29772
2 EX-99.1 d450090dex991.htm EX-99.1 12117
6 GRAPHIC g450090g0508053911654.jpg GRAPHIC 2165
  Complete submission text file 0001193125-23-137703.txt   168727

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ctlt-20230508.xsd EX-101.SCH 2840
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctlt-20230508_lab.xml EX-101.LAB 17234
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctlt-20230508_pre.xml EX-101.PRE 10805
8 EXTRACTED XBRL INSTANCE DOCUMENT d450090d8k_htm.xml XML 3216
Mailing Address 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873
Business Address 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873 (732) 537-6200
Catalent, Inc. (Filer) CIK: 0001596783 (see all company filings)

IRS No.: 208737688 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-36587 | Film No.: 23895913
SIC: 2834 Pharmaceutical Preparations